RecruitingNCT03362164
Evaluation of HEArt invoLvement in Patients With FABRY Disease
Prospective Monocentric Cohort Study to Evaluate Predictors for Heart Failure and Sudden Cardiac Death in Patients With Fabry Disease
Sponsor
Wuerzburg University Hospital
Enrollment
650 participants
Start Date
Jan 1, 2001
Study Type
OBSERVATIONAL
Conditions
Summary
This study evaluates predictors for the incidence of arrhythmias and sudden cardiac death as well as terminal heart failure in patients with Fabry disease.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Fabry disease (genetically confirmed)
- Signed informed consent
- years and older
Exclusion Criteria2
- No informed consent
- Withdrawal of informed consent
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03362164
Related Trials
A Study of Patients With Fabry Disease (US Specific)
NCT069063677 locations
Fabry Disease Registry & Pregnancy Sub-registry
NCT00196742283 locations
Long Duration Holter ECG in Fabry Disease
NCT044402541 location
Rheopheresis as Adjuvant Treatment of Calciphylaxis
NCT0465400029 locations
Longitudinal Studies of Patient With FPDMM
NCT038543181 location